About Mem Methylergometrine 0.2mg Injection
| Brand Name |
Mem 0.2mg Injection
|
| Manufacturer |
Neon Laboratories Ltd
|
| Packaging Type |
1 ml in 1 vial
|
| Composition |
Methylergometrine 0.2mg
|
| Usage/Application |
Post-delivery bleeding
|
| Country of Origin |
Made in India
|
Introduction of Mem 0.2mg Injection:
Mem 0.2mg Injection is a medication used to control draining from the uterus, that might happen after labor or a fetus removal. It chips away at the smooth muscle of the uterus and builds tone, rate, and plentifulness of withdrawals in this way lessens blood misfortune.
Potent Uterotonic for Postpartum Hemorrhage ControlMethylergometrine 0.2mg Injection is specifically developed to effectively manage and prevent postpartum hemorrhage due to uterine atony. Its rapid uterotonic action helps contract the uterus after delivery, minimizing the risk of excessive bleeding and supporting safer postpartum recovery. This makes it an essential medicine for maternal healthcare worldwide.
Strict Administration Guidelines for SafetyThis injection must be administered only by qualified healthcare professionals. The recommended dose is 0.2 mg given intramuscularly or intravenously after delivery, as advised by medical personnel. Strict adherence to dosage and patient monitoring is crucial, particularly avoiding use in hypertensive patients to prevent adverse effects.
Quality and Regulatory AssuranceManufactured in India to meet WHO-GMP certification standards, Methylergometrine 0.2mg Injection assures consistent quality, safety, and efficacy. Its clear, colorless appearance and robust packaging protect the medicine from light and moisture, while the 24-month shelf life enables convenient storage and distribution across healthcare settings.
FAQ's of Mem Methylergometrine 0.2mg Injection:
Q: What is Methylergometrine 0.2mg Injection used for?
A: Methylergometrine 0.2mg Injection is primarily used for the prevention and treatment of postpartum hemorrhage caused by uterine atony in women after childbirth.
Q: How is Methylergometrine 0.2mg Injection administered?
A: The injection is given intramuscularly or intravenously by a healthcare professional, usually after delivery of the anterior shoulder or the placenta, following a physician's instructions.
Q: When should Methylergometrine 0.2mg Injection not be used?
A: It is contraindicated in women with preeclampsia, eclampsia, hypertension, or known hypersensitivity to ergot alkaloids, as well as those allergic to its ingredients.
Q: What are the storage requirements for this injection?
A: The ampoules should be stored below 25C, protected from light and moisture, to maintain efficacy throughout the 24-month shelf life.
Q: Where is Methylergometrine 0.2mg Injection manufactured?
A: This product is manufactured in India and complies with WHO-GMP standards, ensuring global quality and safety regulations are met.
Q: What are the main benefits of using Methylergometrine 0.2mg Injection after childbirth?
A: It significantly reduces the risk of postpartum hemorrhage by promoting uterine contractions, thereby helping control bleeding and improving maternal safety during the postpartum period.
Q: Who should administer Methylergometrine 0.2mg Injection?
A: Only trained healthcare professionals should administer this injection to ensure correct dosing and monitoring for possible contraindications or side effects.